Myeloproliferative Neoplasm Quality Of Life (MPN-QOL) Study Group: Observational Study Of Quality Of Life and Symptomatic Response In Myelofibrosis Patients Receiving Undergoing Treatment With Conventional Therapy, The Measures Trial and Allogeneic Stem Cell Transplant, The Symptoms Trial
Veena Fauble(Mayo Clinic in Arizona), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Gunnar Birgegård(Uppsala University Hospital), Aaron T. Gerds(Cleveland Clinic), Deepti Radia(St Thomas' Hospital), Constantine S. Tam(The Alfred Hospital), Emily Knight(Mayo Clinic in Arizona), David M. Ross(Flinders Medical Centre), Björn Andréasson(NU Hospital Group), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Holly L. Geyer(Mayo Clinic Hospital), Jan Michiels(VIB-KU Leuven Center for Microbiology), Uday Popat(The University of Texas MD Anderson Cancer Center), Vikas Gupta(Indian Institute of Technology Kanpur), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Bart L. Scott(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Christen Lykkegaard Andersen(Copenhagen University Hospital), Robyn M. Emanuel(Centre Hospitalier Universitaire de Grenoble), Michael Boxer(Arizona Oncology), Amylou C. Dueck(Mayo Clinic in Arizona), Peter Johansson(Sahlgrenska University Hospital), Jean‐Loup Demory(Centre Hospitalier Universitaire de Lille), Nicolaus Kröger(Universität Hamburg), Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Elisabeth Ejerblad(Uppsala University)
Cited by 2
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k